Poorer Exercise Capacity Persists With Ventricular Septal Defects
Difference between patients with surgically repaired, unrepaired VSDs versus controls increased with age
Guidelines Updated for Managing Dyslipidemia to Cut CVD Risk
Moderate-dose statin therapy recommended for patients with 10-year CVD risk ≥12 percent
Heavy Sugar-Sweetened Drink Intake Decreasing Overall in U.S.
Heavy SSB intake up for adults ≥60 years; no change seen for those age 40 to 59 years, non-Mexican Hispanics
Measures of Central Adiposity Linked to All-Cause Mortality
Waist circumference, waist-to-hip ratio, waist-to-height ratio linked to increased all-cause mortality
Major Adverse CV Event Risk Reduced With SGLT2 Inhibitors
Risks for MACE, MI, cardiovascular death, heart failure, all-cause mortality lower versus DPP-4 inhibitors
Stroke ‘Alarm Clock’ Improves Acute Stroke Management Metrics
Time from door to completion of diagnostic work-up improved with feedback-demanding clock
Fewer Women Aware of Heart Disease as Leading Cause of Death
Among U.S. women, decrease in awareness seen for all races/ethnicities, all ages except ≥65 years
Oral Steroids May Raise Risks for Diabetes, HTN, VTE in Children
But absolute risks for these complications still low among children receiving glucocorticoids
Air Pollution May Raise Stroke Risk With Atrial Fibrillation
Findings account for neighborhood-specific pollution data, sociodemographic factors
Adverse Pregnancy Outcomes Tied to Later Atherosclerotic CVD
Findings remain when adjusting for standard risk factors, other adverse pregnancy outcomes
